Riskpilot← Back to searchSign inGet full accessDiagnostiskt Centrum Hud i Göteborg AB
ABDissolvedOrg 5590114913Hospital activities · NACE 8610Est. 20154 employees
Revenue 2021
SEK 8,6M
-3% vs 2020
EBITDA margin
-17.8%
-434% vs 2020
Equity ratio
5.6%
Financial strength
Net profit 2021
SEK -1K
-101% vs 2020
| Revenue | SEK 8,6M | -3% |
| EBITDA | SEK -1,5M | -434% |
| Net profit | SEK -1K | -101% |
| Total assets | SEK 6,5M | +28% |
| Equity | SEK 363K | +0% |
| Employees | 4 | — |
Legal name
Diagnostiskt Centrum Hud i Göteborg AB
Org number
5590114913
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
22 april 2015
Share capital
SEK 0
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva diagnostisk konsultverksamhet, specialistkliniker samt forskning och utveckling inom hälso- och sjukvårdsområdet, samt äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9 586 | 12 303 | 11 744 | 8 856 | 8 578 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 442 | 521 | −2 093 | −285 | −1 523 |
| Depreciation & amort. | −121 | −161 | −198 | −191 | −160 |
| EBIT | 321 | 360 | −2 291 | −476 | −1 683 |
| Net financials | −9 | −6 | −11 | −47 | −30 |
| Profit before tax | 227 | 14 | 23 | 179 | 1 |
| Tax | −55 | −14 | −16 | −47 | −2 |
| Net profit | 172 | 0 | 7 | 132 | −1 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 2 426 | 7 212 | 7 855 | 5 047 | 6 472 |
| Equity | 294 | 295 | 302 | 364 | 363 |
| Long-term debt | 0 | 0 | 1 417 | 417 | 0 |
| Short-term debt | 2 047 | 6 834 | 5 939 | 4 070 | 5 996 |
| Total debt | 2 047 | 6 834 | 7 356 | 4 487 | 5 996 |
EBITDA margin
-17.8%
This company
15.8%
Market median
-213% vs market
20172021
Equity ratio
5.6%
This company
38.2%
Market median
-85% vs market
20172021
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20172021
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20172021
Asset turnover
1.33×
This company
1.12×
Market median
+19% vs market
20172021
Debt / equity
16.83×
This company
0.62×
Market median
-2615% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KK Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Diagnostiskt Centrum Hud i Göteborg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kajsa Karin Helena Goding | Chief Auditor | 0 companies |
| Carl Magnus Philip Jerlmyr | Chairman | 0 companies |
| Petra Christin Verga Kan | Board of Directors | 0 companies |
| Lars Magnus Bäcklund | Deputy Board Member | 0 companies |
| Kerstin Anne Margrete Wetter | Deputy Board Member | 0 companies |